NeueHealth CFO Jay Matushak sells $16,892 in common stock

Published 14/03/2025, 02:50
NeueHealth CFO Jay Matushak sells $16,892 in common stock

NeueHealth, Inc. (NASDAQ:NEUE) Chief Financial Officer Jay Matushak recently reported the sale of company stock worth approximately $16,892, according to a filing with the Securities and Exchange Commission. The transaction comes as the stock has experienced an 8.6% decline over the past week, though it maintains a strong 25.8% gain over the last six months. According to InvestingPro analysis, the stock currently appears undervalued relative to its Fair Value. The transactions, which took place on March 11 and March 12, involved the sale of 814 shares at prices ranging from $6.83 to $6.90 per share, and 1,633 shares at prices between $6.71 and $6.98 per share. With the company’s next earnings report scheduled for March 20, investors following this insider activity can access additional insights through InvestingPro, which offers 12 more exclusive tips about NEUE’s financial health and market position.

In addition to these sales, Matushak exercised options to acquire 24,000 shares of common stock on March 12, although this transaction did not involve any cash exchange. Following these transactions, Matushak’s direct ownership in NeueHealth stands at 46,040 shares.

The sales of the shares were undertaken to cover tax withholding obligations upon the vesting of restricted stock units, as noted in the filing.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.